1. Both Epstein-Barr virus (EBV)-encoded trans-activity factors, EB1 and EB2, are required to activate transcription from the EBV early promoter;Chevalier-Greco;Eur. Mol. Biol. Organ. J.,1986
2. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency;Countryman;J. Virology,1987
3. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated BamWYH region of EBV DNA: preferential expression in lymphoblastoid cell lines;Dillner,1986
4. Activation of the EBV-cycle and aggregation of human blood lymphocytes by tumor promoters telocidin, lyngbyatoxin A, aplysiatoxin and debromoaplysiatoxin;Eliasson;Int. J. Cancer,1983
5. Transfection of a rearranged viral DNA fragment, WZhet stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells;Grogan,1987